Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors

被引:28
|
作者
Zarghi, Afshin [1 ]
Kakhgi, Samaneh [1 ]
Hadipoor, Atefeh [1 ]
Daraee, Bahram [2 ]
Dadrass, Orkideh G. [3 ]
Hedayati, Mehdi [4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Pharmaceut Chem, Sch Pharm, Tehran, Iran
[2] Tarbiat Modares Univ, Tehran, Iran
[3] Azad Univ, Sch Pharm, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran, Iran
关键词
1,3-diarylurea; COX-2; inhibition; SAR;
D O I
10.1016/j.bmcl.2008.01.021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A group of 1,3-diarylurea derivatives, possessing a methylsulfonyl pharmacophore at the para-position of the N-1 phenyl ring, in conjunction with a N-3 substituted-phenyl ring (4-F, 4-Cl, 4-Me, 4-OMe), were designed and synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 isozyme inhibition structure - activity studies identified 1-(4methylsulfonylphenyl)-3-(4- methoxyphenyl) urea (4e) as a potent COX-2 inhibitor (IC50 = 0.11 mu M) with a high COX-2 selectivity index ( SI = 203.6) comparable to the reference drug celecoxib (COX-2 IC50 = 0.06 mu M; COX-2 SI =405). The structure - activity data acquired indicate that the urea moiety constitutes a suitable scaffold to design new acyclic 1,3-diarylurea derivatives with selective COX-2 inhibitory activity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1336 / 1339
页数:4
相关论文
共 50 条
  • [41] Selective inhibitors of COX-2
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 79 - 80
  • [42] Design of peptides and peptidomimetics as COX-2 selective inhibitors
    Kothekar, V
    Sahi, S
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 577 (2-3): : 107 - 120
  • [43] Selective COX-2 inhibitors
    Parnham, MJ
    DRUG NEWS & PERSPECTIVES, 1997, 10 (03) : 182 - 187
  • [44] Selective COX-2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (03) : 122 - 122
  • [45] Selective COX-2 inhibitors
    Pasero, C
    McCaffery, M
    AMERICAN JOURNAL OF NURSING, 2001, 101 (04) : 55 - 56
  • [46] Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme
    Uddin, MJ
    Rao, PNP
    McDonald, R
    Knaus, EE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) : 439 - 442
  • [47] Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
    Al-Hourani, Baker Jawabrah
    Sharma, Sai Kiran
    Mane, Jonathan Y.
    Tuszynski, Jack
    Baracos, Vickie
    Kniess, Torsten
    Suresh, Mavanur
    Pietzsch, Jens
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1823 - 1826
  • [48] Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors
    Abdellatif, Khaled R. A.
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Zidan, Taha H.
    ARCHIV DER PHARMAZIE, 2017, 350 (08)
  • [49] Synthesis of Deuterated Benzopyran Derivatives as Selective COX-2 Inhibitors with Improved Pharmacokinetic Properties
    Zhang, Yanmei
    Tortorella, Micky D.
    Wang, Yican
    Liu, Jianqi
    Tu, Zhengchao
    Liu, Xiaorong
    Bai, Yang
    Wen, Dingsheng
    Lu, Xin
    Lu, Yongzhi
    Talley, John J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (10): : 1162 - 1166
  • [50] Design, synthesis and biological evaluation of new tricyclic spiroisoxazoline derivatives as selective COX-2 inhibitors and study of their COX-2 binding modes via docking studies
    Abolhasani, Hoda
    Dastmalchi, Siavoush
    Hamzeh-Mivehroud, Maryam
    Daraei, Bahram
    Zarghi, Afshin
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (05) : 858 - 869